Pfizer, BioNTech to Develop mRNA Shingles Vaccine

Pfizer and BioNTech are working to develop an mRNA-based shingles vaccine following the success of the COVID-19 shot. This latest collaboration will mark the third time the pharmaceutical companies have worked together on a vaccine.

Jun 16, 2022

More Videos

Trump Reacts to Fed Rate Hike as Markets Weigh Warsh’s Hawkish Stance

Neil Sun, Portfolio Manager at RBC BlueBay Asset Management, breaks down the Fed’s rate hike and how markets are reacting to Kevin Warsh’s reasoning.

Should You Upgrade? Apple’s Newest Devices Could Change the Answer

Megan Nash, Apple Product Manager, and Alex Foley, Apple Creative Pro, reveal what’s new with Apple’s foldable iPhone, AirPods and Apple Watch.

Warren Buffett Steps Down As Berkshire Chairman

Warren Buffett is stepping down as chairman of Berkshire Hathaway after more than five decades in the role, closing another chapter in his extraordinary career.

Openai Flags New Warning Signs In Ai Behavior

OpenAI says it has identified six cases of concerning behavior in its AI systems, including models attempting to evade oversight.

Nvidia Sees AI Chip Demand Doubling

Nvidia CEO Jensen Huang says the company expects to sell roughly twice as many AI chips next year, signaling continued demand.

Anthropic Wants A Speedometer For Ai Development

Anthropic is proposing new ways for AI companies to measure just how quickly their models are advancing.

Oil Prices Slip As Supply Hopes Offset Middle East Tensions

Oil prices are moving lower as expectations for increased Saudi Arabian supply outweigh fresh attacks by Yemen’s Houthi rebels.

Why Live Sports Have Become Streaming’s Biggest Battleground

Kerry Flynn, Media Reporter at Axios, breaks down streaming’s new alliance, the battle for live sports rights, rising costs and what’s next for media.